Upgrade to SI Premium - Free Trial

Form SCHEDULE 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT

April 8, 2026 6:05 AM





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Shah Capital Management
Signature:/s/ Himanshu H. Shah
Name/Title:Himanshu H. Shah, President and Chief Investment Officer
Date:04/08/2026
Shah Capital Opportunity Fund LP
Signature:/s/ Himanshu H. Shah
Name/Title:Himanshu H. Shah, Managing Member
Date:04/08/2026
Himanshu H. Shah
Signature:/s/ Himanshu H. Shah
Name/Title:Himanshu H. Shah
Date:04/08/2026

ATTACHMENTS / EXHIBITS

fp0098293-1_ex991.htm

Categories

SEC Filings

Next Articles